SynthesisAesthetic plastic surgery2025
Outcomes and Risk Factors of Pyoderma Gangrenosum After Reduction Mammoplasty: A Systematic Review of the Literature and Case Report.
Synthesis in Aesthetic plastic surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Pyoderma Gangrenosum Can Now Be Diagnosed Reliably with Validated Scores.Aesthetic plastic surgery · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundReduction mammoplasty is a common aesthetic and reconstructive breast procedure. Pyoderma gangrenosum (PG) is a rare inflammatory, non-infectious neutrophilic dermatosis. Post-surgical PG is characterized by ulcerative lesions at surgical sites commonly misdiagnosed as wound infection. The present systematic review was conducted to retrieve the potential factors and outcomes of post-reduction mammoplasty PG with a case report.
methodsAn extensive systematic literature review was implemented from inception to 18 October 2024. All clinical studies that included patients with PG after reduction mammoplasty were included for systematic review.
resultsA female patient presented ten days after reduction mammoplasty with bilateral wound dehiscence. Thirty-nine days after the operation, the wound showed a second dehiscence for which immunosuppressive drugs were prescribed. The patient responded to the latest regimen with complete healing of the ulcerative lesions of the right and left breasts. The present systematic review included 41 cases, encompassing the present case report. The median time to initial presentation of PG was 6.5 days. The median time to the diagnosis of PG was 15.5 days. The wound was healed by secondary intention among 26 (59.06%) patients. Skin grafting was performed for six (13.63%) patients, while three (6.81%) patients received skin substitutes.
conclusionPG after reduction mammoplasty is a devastating condition associated with poor cosmetic outcomes. The condition is difficult to diagnose, and the majority of cases are misdiagnosed and potentially subjected to ineffective medical therapy and unnecessary surgical debridement that worsen the prognosis of PG. Patients with existing immunological disorders and patients with a history of breast cancer were at higher risk of developing PG after reduction mammoplasty. The risk of PG after reduction mammoplasty still existed despite undergoing previous breast or abdominal surgeries. Patients with post-reduction mammoplasty PG mostly presented with erythema, severe pain, and fever. LEVEL OF EVIDENCE III: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.